Predicting the clinical citation count of biomedical papers using multilayer perceptron neural network
Reviewed by Pith T0 review T1 audit T2 compute T3 formal T4 kernel pith:LAXCDH2Urecord.jsonopen to challenge →
read the original abstract
The number of clinical citations received from clinical guidelines or clinical trials has been considered as one of the most appropriate indicators for quantifying the clinical impact of biomedical papers. Therefore, the early prediction of the clinical citation count of biomedical papers is critical to scientific activities in biomedicine, such as research evaluation, resource allocation, and clinical translation. In this study, we designed a four-layer multilayer perceptron neural network (MPNN) model to predict the clinical citation count of biomedical papers in the future by using 9,822,620 biomedical papers published from 1985 to 2005. We extracted ninety-one paper features from three dimensions as the input of the model, including twenty-one features in the paper dimension, thirty-five in the reference dimension, and thirty-five in the citing paper dimension. In each dimension, the features can be classified into three categories, i.e., the citation-related features, the clinical translation-related features, and the topic-related features. Besides, in the paper dimension, we also considered the features that have previously been demonstrated to be related to the citation counts of research papers. The results showed that the proposed MPNN model outperformed the other five baseline models, and the features in the reference dimension were the most important.
This paper has not been read by Pith yet.
Forward citations
Cited by 1 Pith paper
-
MIRAI: Prediction and Generation of High-Impact Academic Research
MIRAI predicts 5-year PageRank and citation impact from paper title/abstract/date with Spearman's ρ 0.47/0.62, and generates ideas judged 4:3 more impactful by LLM.
discussion (0)
Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.